0001070081-19-000034.txt : 20190603 0001070081-19-000034.hdr.sgml : 20190603 20190603173944 ACCESSION NUMBER: 0001070081-19-000034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190531 FILED AS OF DATE: 20190603 DATE AS OF CHANGE: 20190603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hill Emily Luisa CENTRAL INDEX KEY: 0001778279 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 19874499 MAIL ADDRESS: STREET 1: C/O PTC THERAPEUTICS, INC. STREET 2: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 4 1 wf-form4_155959796974204.xml FORM 4 X0306 4 2019-05-31 0 0001070081 PTC THERAPEUTICS, INC. PTCT 0001778279 Hill Emily Luisa C/O PTC THERAPEUTICS INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 0 1 0 0 Chief Financial Officer Common Stock 7605 D Stock Option (Right To Buy) 40.1 2019-05-31 4 A 0 50000 40.10 A 2029-05-30 Common Stock 50000.0 50000 D Stock Option (Right To Buy) 43.69 2024-09-24 Common Stock 7000.0 7000 D Stock Option (Right To Buy) 51.0 2025-01-02 Common Stock 1620.0 1620 D Stock Option (Right To Buy) 30.86 2026-01-03 Common Stock 2430.0 2430 D Stock Option (Right To Buy) 11.23 2027-01-02 Common Stock 3825.0 3825 D Stock Option (Right To Buy) 18.01 2028-01-03 Common Stock 14000.0 14000 D Stock Option (Right To Buy) 33.02 2029-01-21 Common Stock 21210.0 21210 D This option was granted on May 31, 2019 and vests over four years, with 25% of the shares underlying the option vesting on May 31, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning August 31, 2020. Currently exercisable. This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017. This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018. This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020. Avraham S. Adler, attorney-in-fact 2019-06-03